Michael Grissinger

Insider Reports History

Location
C/O Restorbio, Inc., 500 Boylston St., 12 Th Floor, Boston, MA
Signature
/s/ John Hamill, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Grissinger:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aprea Therapeutics, Inc. Director Common Stock 2.89K $4.68K $1.62 Jun 5, 2025 Direct
Akari Therapeutics Plc Director Ordinary Shares, par value $0.0001 per share 20M Jan 1, 2024 Direct
Akari Therapeutics Plc Director Stock Option (Right to Buy) 5M Jun 28, 2024 Direct
Adicet Bio, Inc. Director Stock Option (Right to Buy) 70.2K Apr 17, 2025 Direct
Aprea Therapeutics, Inc. Director Stock Options (Right to Buy) 4.19K Jun 20, 2024 Direct
Aprea Therapeutics, Inc. Director Stock Options (Right to Buy) 4.19K Jun 5, 2025 Direct

Insider Reports Filed by Michael Grissinger

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APRE Aprea Therapeutics, Inc. Jun 5, 2025 2 $0 4 Jun 9, 2025 Director
ACET Adicet Bio, Inc. Apr 17, 2025 1 $0 4 Apr 21, 2025 Director
ACET Adicet Bio, Inc. Apr 17, 2025 0 $0 3 Apr 21, 2025 Director
AKTX Akari Therapeutics Plc Jun 28, 2024 1 $0 4 Jul 2, 2024 Director
APRE Aprea Therapeutics, Inc. Jun 20, 2024 2 $0 4 Jun 21, 2024 Director
AKTX Akari Therapeutics Plc Jan 1, 2024 0 $0 3 Jan 2, 2024 Director
APRE Aprea Therapeutics, Inc. Aug 23, 2023 2 $0 4 Aug 24, 2023 Director
APRE Aprea Therapeutics, Inc. Jul 28, 2022 2 $0 4 Aug 1, 2022 Director
APRE Aprea Therapeutics, Inc. May 16, 2022 0 $0 3 May 26, 2022 Director